General Information
Version
1.0
Revision date
2024-02-26
Product name
NimaPrime Conditioning Reagent 3500/SeqStudio Flex
1.2.1 Relevant identified uses
Professional use
Emergency telephone
+43 1 406 43 43, +32 70 245 245, +359 2 9154 233, +385 1 234 8342, +420 224 919 293, +420 224 915 402, +45 82 12 12 12, +372 7943 794, +358 800 147 111, +358 9 471 977, 0800 147 111, +33 1 45 42 59 59, +33 4 91 75 25 25, +33 1 40 05 48 48, +49 (0) 228 19240, +49 (0) 761 19240, +49 (0) 551 19240, +30 21 07 79 37 77, +36 80 20 11 99, +36 1 476 6464, +354 543 22 22, +354 543 10 00, +353 1 809 2566, +353 1 809 2166, 02 6610 1029, 06 305 4343, +371 67 04 24 73, +370 (85) 236 20 52, +352 8002 5500, +356 2545 6...
Icons in SDS
Company Information
company name
NimaGen B.V
e-mail address of the competent person responsible for the Safety Data Sheet
info@nimagen.com
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice
2.3 Other hazards
The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Not classified Adverse physicochemical, human health and environmental effects To our knowledge, this product does not present any particular risk, provided it is handled in accordance with good occupational hygiene and safety practice.
